Brenda Libby Coleman

Array ( [id] => 5480620 [patent_doc_number] => 20090203577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Azepinoindole Derivatives As Pharmaceutical Agents' [patent_app_type] => utility [patent_app_number] => 12/096961 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 77998 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203577.pdf [firstpage_image] =>[orig_patent_app_number] => 12096961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5096178 [patent_doc_number] => 20070117787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Benzoxazepine compounds, their production and use' [patent_app_type] => utility [patent_app_number] => 11/638066 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20956 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117787.pdf [firstpage_image] =>[orig_patent_app_number] => 11638066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977964 [patent_doc_number] => 20070219197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives' [patent_app_type] => utility [patent_app_number] => 11/635157 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26611 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219197.pdf [firstpage_image] =>[orig_patent_app_number] => 11635157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041193 [patent_doc_number] => 20070093475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Short-acting benzodiazepines' [patent_app_type] => utility [patent_app_number] => 11/634788 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19009 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093475.pdf [firstpage_image] =>[orig_patent_app_number] => 11634788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949916 [patent_doc_number] => 20080306042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Triazole Derivatives' [patent_app_type] => utility [patent_app_number] => 12/158344 [patent_app_country] => US [patent_app_date] => 2006-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18624 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306042.pdf [firstpage_image] =>[orig_patent_app_number] => 12158344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949919 [patent_doc_number] => 20080306045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => '1-Benzazepine-3-Sulfonylamino-2-Pyrroridones as Factor Xa Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/094707 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24094 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306045.pdf [firstpage_image] =>[orig_patent_app_number] => 12094707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 885087 [patent_doc_number] => 07351839 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Process for the preparation of 1,2,3,4,8,9,10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino-[6,7,1-hi]indole derivatives' [patent_app_type] => utility [patent_app_number] => 11/602531 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5298 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351839.pdf [firstpage_image] =>[orig_patent_app_number] => 11602531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453254 [patent_doc_number] => 20090069291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Salt Forms' [patent_app_type] => utility [patent_app_number] => 12/093952 [patent_app_country] => US [patent_app_date] => 2006-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5980 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069291.pdf [firstpage_image] =>[orig_patent_app_number] => 12093952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189120 [patent_doc_number] => 20070167429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => '4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative or salt thereof' [patent_app_type] => utility [patent_app_number] => 11/598732 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20623 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167429.pdf [firstpage_image] =>[orig_patent_app_number] => 11598732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4972187 [patent_doc_number] => 20070112190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/599580 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18515 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20070112190.pdf [firstpage_image] =>[orig_patent_app_number] => 11599580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057669 [patent_doc_number] => 20070060591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Chemokine receptor binding heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 11/599066 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30193 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060591.pdf [firstpage_image] =>[orig_patent_app_number] => 11599066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596106 [patent_doc_number] => 07981884 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Process for the preparation of olanzapine' [patent_app_type] => utility [patent_app_number] => 12/093344 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4035 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981884.pdf [firstpage_image] =>[orig_patent_app_number] => 12093344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484550 [patent_doc_number] => 07902182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/595429 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22167 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902182.pdf [firstpage_image] =>[orig_patent_app_number] => 11595429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112025 [patent_doc_number] => 07718649 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-05-18 [patent_title] => 'Physical states of a pharmaceutical drug substance' [patent_app_type] => utility [patent_app_number] => 11/595379 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 9253 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718649.pdf [firstpage_image] =>[orig_patent_app_number] => 11595379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515519 [patent_doc_number] => 07932248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => '1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/594993 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26498 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932248.pdf [firstpage_image] =>[orig_patent_app_number] => 11594993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299930 [patent_doc_number] => 07538129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Diazonamide A analog' [patent_app_type] => utility [patent_app_number] => 11/591016 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7019 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538129.pdf [firstpage_image] =>[orig_patent_app_number] => 11591016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971981 [patent_doc_number] => 20070111984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/590637 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43128 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111984.pdf [firstpage_image] =>[orig_patent_app_number] => 11590637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688886 [patent_doc_number] => 20070105812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Lipid analogs for inhibiting HIV-1 activity' [patent_app_type] => utility [patent_app_number] => 11/588311 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8203 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105812.pdf [firstpage_image] =>[orig_patent_app_number] => 11588311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035331 [patent_doc_number] => 20070099870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Lipid analogs for combating tumors' [patent_app_type] => utility [patent_app_number] => 11/588313 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8224 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099870.pdf [firstpage_image] =>[orig_patent_app_number] => 11588313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688887 [patent_doc_number] => 20070105811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Lipid analogs for inhibiting the activity of hepatitis B antigen' [patent_app_type] => utility [patent_app_number] => 11/588308 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8206 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105811.pdf [firstpage_image] =>[orig_patent_app_number] => 11588308 [rel_patent_id] =>[rel_patent_doc_number] =>)